Suchergebnisse - (Person:"Spalluto, Giampiero")

PubPharm (34)

1

5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors

enthalten in: European journal of medicinal chemistry | 2016

von Ciancetta, A. | Cacciari, B. | Pastorin, G. | +6

2

Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists

enthalten in: Current topics in medicinal chemistry | 2016

von Redenti, S. | Ciancetta, A. | Pastorin, G. | +4

3

Advances in Computational Techniques to Study GPCR-Ligand Recognition

enthalten in: Trends in pharmacological sciences | 2015

von Ciancetta, A. | Sabbadin, D. | Federico, S. | +2

4

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile

enthalten in: Purinergic signalling | 2007

von Lambertucci, C. | Cristalli, G. | Dal Ben, D. | +5

5

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes

enthalten in: Purinergic signalling | 2007

von Bolcato, C. | Cusan, C. | Pastorin, G. | +5

6

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure–activity profile

enthalten in: Purinergic signalling | 2006

von Cacciari, B. | Bolcato, C. | Spalluto, G. | +4

7

The application of a 3D-QSAR (autoMEP/PLS) approach as an efficient pharmacodynamic-driven filtering method for small-sized virtual library : application to a lead optimization of a human A3 adenosine receptor antagonist

enthalten in: Bioorganic & medicinal chemistry | 2006

von Moro, S. | Bacilieri, M. | Cacciari, B. | +5

8

A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro

enthalten in: British journal of pharmacology | 2006

von Pugliese, A. | Coppi, E. | Spalluto, G. | +2

9

Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations

enthalten in: Journal of medicinal chemistry | 2006

von Pastorin, G. | Da Ros, T. | Bolcato, C. | +7

10

Progress in the pursuit of therapeutic adenosine receptor antagonists

enthalten in: Medicinal research reviews | 2006

von Moro, S. | Gao, Z. | Jacobson, K. | +1